Mehrdad Zarrinmakan, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 8952 E Market St, Warren, OH 44484 Phone: 330-856-4366 Fax: 330-856-9656 |
Dr. Eugene Victor Vitvitsky, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1950 Niles Cortland Rd Ne Ste 12, Warren, OH 44484 Phone: 330-282-6301 Fax: 330-451-5764 |
Alejandro A Franco, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 8600 E Market St Ste 8, Warren, OH 44484 Phone: 330-288-0583 Fax: 330-288-0586 |
News Archive
Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer, particularly if their cancer is fueled by the hormones estrogen or progesterone, according to a data analysis by researchers at Boston's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard School of Public Health.
A telemedicine initiative in Vanderbilt's Department of Hearing and Speech Sciences is working to make follow-up hearing tests for newborns more accessible in rural areas of Tennessee, while teaching young pediatric audiology and pediatric speech language pathology students to treat patients remotely.
A new study published on the preprint server bioRxiv* in August 2020 shows that the man-made compound silicon nitride, which is used in medical implants and high mechanical performance engineering applications, is capable of inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at varying concentrations without causing cell cytotoxicity. This finding should be investigated to develop disinfectants to clear the virus from surfaces, preventing its spread.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
› Verified 6 days ago